Loading...

Cost Optimization And Industrial Demand Will Shape Future Markets

Published
11 Sep 24
Updated
07 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-75.1%
7D
-49.5%

Author's Valuation

US$8.7553.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 07 Nov 25

Fair value Decreased 8.70%

ASPN: Reduced EV Tax Credits Will Challenge Thermal Segment Performance Ahead

Analysts have lowered their price target for Aspen Aerogels from $9.58 to $8.75. They cited reduced electric vehicle production forecasts and increased macroeconomic pressures on the company’s key Thermal Barrier business segment.

Analyst Commentary

Recent analyst coverage on Aspen Aerogels reflects a cautious outlook, with updates that highlight both potential opportunities and risks facing the company.

Bullish Takeaways

  • Bullish analysts note that Aspen Aerogels' Thermal Barrier segment continues to deliver strong growth and maintains strategic importance in the electric vehicle supply chain.
  • The company’s established partnerships with major automakers position it to benefit if electric vehicle production volumes exceed current reduced forecasts.
  • Existing product differentiation and proprietary aerogel technology are considered competitive strengths that could support future margin expansion and market share gains.
  • Cost reduction initiatives and focused operational execution may help offset some external headwinds and support profitability over time.

Bearish Takeaways

  • Bearish analysts are concerned about the heavy dependence on automotive clients, particularly General Motors, making Aspen Aerogels' growth tightly linked to industry-specific production trends.
  • The removal of key government incentives, such as the $7,500 electric vehicle tax credit, is expected to reduce demand and could directly affect the company’s growth projections and valuation.
  • Thermal Barrier gross margins are highly sensitive to changes in production scales, increasing risk as macroeconomic pressures cause automakers to slow output.
  • Overall, macroeconomic challenges and reduced visibility into end-market demand have led to further caution regarding the pace of recovery and sustainable top-line growth.

What's in the News

  • Aspen Aerogels revised its full-year 2025 earnings guidance and now projects revenue of $270 million to $280 million. This is down from the previous range of $297 million to $317 million. The company also expects a higher net loss and loss per share compared to earlier forecasts (Key Developments).
  • The company provided fourth quarter 2025 revenue guidance, anticipating between $40 million and $50 million in revenue (Key Developments).
  • Guidance for impairment of property, plant, and equipment was updated for 2025. It is now expected at $287.6 million compared to previous guidance of $287.57 million (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has decreased modestly from $9.58 to $8.75, reflecting tempered expectations for near-term performance.
  • Discount Rate has edged down slightly from 7.91% to 7.80%, indicating a small reduction in perceived investment risk.
  • Revenue Growth projections have risen sharply, moving from 8.92% to 18.14%. Updated forecasts anticipate stronger top-line expansion.
  • Net Profit Margin estimates have increased from 12.26% to 14.76%, suggesting improved expectations for company profitability.
  • Future P/E (Price-to-Earnings) Ratio has declined significantly from 15.88x to 10.60x, pointing to a lower valuation multiple based on projected earnings.

Key Takeaways

  • Cost reductions and process improvements are enhancing profitability and positioning the company for stronger earnings even at modest revenue levels.
  • Strategic focus on EV thermal barriers and U.S.-based manufacturing aligns with regulatory trends, supporting future growth and market share expansion.
  • Heavy reliance on key segments and customers, regulatory uncertainty, and ongoing margin pressures threaten growth projections and create revenue and earnings vulnerability.

Catalysts

About Aspen Aerogels
    An aerogel technology company, designs, develops, manufactures, and sells aerogel materials primarily for use in the energy industrial, sustainable insulation materials, and electric vehicle (EV) markets in the United States, Canada, Asia, Europe, and Latin America.
What are the underlying business or industry changes driving this perspective?
  • Aspen's cost optimization-reducing fixed costs by ~$65M and streamlining operations-substantially lowers the revenue threshold needed to achieve profitability. This greater operating leverage, combined with a stable cost structure and controlled CapEx, is set to significantly improve EBITDA and net margin even at modest revenue recovery.
  • Medium-term visibility into a rebound in project-based Energy Industrial revenues (subsea/LNG), as key customers' 2025 wins and robust project backlogs are expected to drive attractive incremental revenue and high gross margins from 2026 onwards.
  • Strong positioning in the EV thermal barrier market with major OEMs like GM, Stellantis, and Daimler, alongside active new quoting and prototyping activities, underpins a path toward multi-year revenue acceleration as electrification in transportation and strict emissions regulations continue to ramp up globally.
  • Ongoing process improvements and increased production efficiency at the Rhode Island and Mexico facilities are driving productivity gains and gross margin expansion, further boosting long-term earnings power and resilience to lower EV production volatility.
  • Domestic manufacturing capacity and flexible sourcing strategies cater to automaker preferences for U.S.-based supply and position Aspen as a preferred supplier amid intensifying regulations favoring energy efficiency and sustainability, supporting long-term revenue growth and market share gains.

Aspen Aerogels Earnings and Revenue Growth

Aspen Aerogels Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Aspen Aerogels's revenue will grow by 8.9% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -78.5% today to 12.3% in 3 years time.
  • Analysts expect earnings to reach $62.9 million (and earnings per share of $0.72) by about September 2028, up from $-311.9 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $32.2 million.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 15.9x on those 2028 earnings, up from -1.8x today. This future PE is lower than the current PE for the US Chemicals industry at 25.9x.
  • Analysts expect the number of shares outstanding to grow by 0.38% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.91%, as per the Simply Wall St company report.

Aspen Aerogels Future Earnings Per Share Growth

Aspen Aerogels Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Slower-than-expected demand recovery in the Energy Industrial segment, with continued destocking by distributors and delayed project activity (especially in subsea and LNG markets), exposes Aspen to prolonged revenue weakness and challenges the assumption of strong growth in this core business.
  • High customer concentration in the EV Thermal Barrier segment, particularly reliance on GM, poses a risk to future revenues and earnings if GM's EV production or market share stalls or declines, as suggested by management noting production levels tracking IHS forecasts and emphasizing GM's outsized impact.
  • Ongoing policy and regulatory volatility in key markets (notably the U.S. EV market) create uncertainty for EV adoption rates and timing of OEM launches, potentially undermining anticipated topline growth and slowing earnings improvement.
  • Adjacent OEM programs, design-in activity, and new platform launches outside of current key customers (e.g., Daimler, Stellantis, ACC) have uncertain timelines or significant slippage due to shifting automaker plans and reaction to changing government incentives, posing risk to the realization of outsized growth projections for 2026-2027.
  • The need for persistent R&D and capital expenditures to remain competitive combined with achieved cost reductions cycling out of the base may limit further margin expansion, while risks such as commodity price volatility and potential industry-wide pricing pressure could negatively impact future gross margins and net income.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $9.583 for Aspen Aerogels based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $14.0, and the most bearish reporting a price target of just $6.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $513.3 million, earnings will come to $62.9 million, and it would be trading on a PE ratio of 15.9x, assuming you use a discount rate of 7.9%.
  • Given the current share price of $6.66, the analyst price target of $9.58 is 30.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives